In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration.
Chao
Mimi
M
Division of Plastic Surgery, School of Medicine, Saint Louis University, St. Louis, Missouri 63110, USA.
Donovan
Tom
T
Sotelo
Cirilio
C
Carstens
Michael H
MH
D001672:Biocompatible Materials / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use*; D001860:Bone Plates; D001861:Bone Regeneration / Q000187:drug effects; D018786:Bone Substitutes / Q000627:therapeutic use; D002130:Calcium Phosphates / Q000627:therapeutic use; D002675:Child, Preschool; D003094:Collagen / Q000627:therapeutic use; D017886:Durapatite / Q000627:therapeutic use; D018214:Fibroma, Ossifying / Q000188:drug therapy / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008334:Mandible / Q000187:drug effects* / Q000601:surgery; D008339:Mandibular Neoplasms / Q000188:drug therapy / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000601:surgery*; D010012:Osteogenesis / Q000187:drug effects*; D010521:Periosteum / Q000187:drug effects / Q000473:pathology; D011994:Recombinant Proteins / Q000627:therapeutic use*; D019651:Plastic Surgery Procedures / Q000295:instrumentation / Q000379:methods; D013234:Stem Cells / Q000187:drug effects*; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*
D001672:Biocompatible Materials; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D018786:Bone Substitutes; D002130:Calcium Phosphates; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2; D003094:Collagen; D017886:Durapatite; C018392:tricalcium phosphate